Federal officials say there's new funding to study the medical potential of a powerful psychedelic. The effort announced Thursday includes nearly $5 million to lay the groundwork for U.S. studies of ibogaine. Ibogaine is made from an African plant and can cause intense hallucinations, nausea, tremors and dangerous heart rhythms. It's currently illegal in the United States. Veterans groups contend ibogaine has great promise for hard-to-treat conditions like post-traumatic stress disorder, severe depression and opioid addiction. President Donald Trump signed an executive order in April directing federal agencies to speed up review and research of psychedelics.
Congo's Ebola outbreak has topped 11,000 cases, highlighting the severity of the situation. The health ministry reported on Wednesday 11,042 infections and 5,387 deaths, making it Congo's deadliest outbreak. The crisis began in mid-May, and authorities have struggled to contain it due to armed conflicts, a health system crisis, poor roads, and violence fueled by mistrust. The Bundibugyo virus responsible for this outbreak has no known vaccine or treatment and has spread to eight provinces. Health workers face attacks, and experts urge more efforts to contain the disease, which has spread to Uganda, Kenya, and Nigeria.
WASHINGTON (AP) — Popular weight loss drugs including Ozempic and Wegovy will carry a new warning about a possible rare side effect that can s…
FILE - The injectable drug Ozempic in Houston on July 1, 2023. (AP Photo/David J. Phillip, File)
MBARARA, Uganda (AP) — In the red light district in Mbarara, a city in western Uganda known in part for sex tourism, a sex worker named Lisa M…
Patients wait for services at the ART clinic at Mbarara City Council Health Center IV in Mbarara, western Uganda, Aug. 21, 2026. (AP Photo/Hajarah Nalwadda)
A nurse prepares a syringe before injecting a patient with the new HIV prevention drug lenacapavir at the ART clinic at Mbarara City Council Health Center IV in western Uganda, Aug. 21, 2026. (AP Photo/Hajarah Nalwadda)
A health worker registers patients at the ART clinic at Mbarara City Council Health Center IV in Mbarara, western Uganda, Aug. 21, 2026. (AP Photo/Hajarah Nalwadda)
A West Point cadet drugged his girlfriend to force an unwanted abortion. Then he went to grad school
NEW YORK (AP) — A onetime West Point cadet drugged his then-girlfriend in her barracks room, administered abortion pills to her against her wi…
The U.S. Food and Drug Administration has approved a generic version of the world’s only twice-a-year shot to prevent HIV. This is a big step toward making the extremely effective drug available inexpensively and quickly in 120 low- and middle-income countries. The drug, called lenacapavir, is expected to cost $40 a person each year in these places, the same price as daily preventive pills available now. But the shots are much more convenient than the pills because they’re needed much less frequently. The generic will not be available in the U.S. because there is a brand-name version still protected by a patent.